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Rozemarijn J van der Vijver*, Cees JHM van Laarhoven, Roger MLM Lomme and Thijs HendriksAbstract
Background: There is increasing evidence that perioperative use of NSAIDs may compromise the integrity of
intestinal anastomoses. This study aims to characterize the negative effects of carprofen on early anastomotic
healing in the rat ileum.
Results: In 159 male Wistar rats an anastomosis was constructed in the ileum. In experiment 1 eighty-four rats were
divided over control and experimental groups, which received daily buprenorphine or carprofen, respectively, as an
analgesic and were killed on day 1, 2 or 3 after surgery. In experiment 2 three groups of 15 rats received carprofen
either immediately after surgery or with a delay of 1 or 2 days. Animals were killed after 3 days of carprofen
administration. In experiment 3 three groups of 10 rats received different doses (full, half or quarter) of carprofen
from surgery.
In significant contrast to buprenorphine, which never did so, carprofen induced frequent signs of anastomotic
leakage, which were already present at day 1. If first administration was delayed for 48 hours, the leakage rate was
significantly reduced (from 80 to 20%; p = 0.0028). Throughout the study, the anastomotic bursting pressure was
lowest in animals who displayed signs of anastomotic leakage. Loss of anastomotic integrity did not coincide with
reduced levels of hydroxyproline or increased activity of matrix metalloproteinases.
Conclusions: Carprofen interferes with wound healing in the rat ileum at a very early stage. Although the
mechanisms responsible remain to be fully elucidated, one should be aware of the potential of NSAIDs to interfere
with the early phase of wound repair.
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The use of analgetics in veterinary medicine is still rela-
tively low, but adequate management of animal pain is
becoming increasingly important in companion, farm
and laboratory animals [1,2].
Human pain control strategies using opiods or non-
steroidal anti-inflammatory drugs (NSAIDs) can be ap-
plied to animals, because most animals possess neuronal
mechanisms for pain perception which are similar to
humans [3]. NSAIDs inhibit cyclo-oxygenases (COXs),
enzymes which catalyze the first two steps in prostanoid
biosynthesis. These enzymes occur as isoforms COX-1
and COX-2. COX-1 is expressed constitutively in house-
keeping functions, whereas COX-2 is expressed mainly
in response to external stimuli. One widely used NSAID* Correspondence: r.vandervijver@chir.umcn.nl
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distribution, and reproduction in any mediumin veterinary medicine is carprofen, which is believed to
possess a certain preference for COX-2 [4] and is suit-
able for pain relief. It is mostly used in dogs and cats but
also in cattle and in laboratory animals. If carprofen is
used as an analgetic during and after surgery of the in-
testine in rats the healing of ileal, but not of colonic,
anastomoses is seriously compromised [5]. A similar ef-
fect was found previously for celecoxib, another inhibi-
tor with a certain degree of specificity for COX-2 [6].
Such a negative effect could have implications for the
use of carprofen in veterinary practice and laboratory
animals, particularly if used in the peri-operative period.
The present experiments were conducted to expand
our earlier preliminary findings [5] and further investi-
gate the effects of carprofen on the healing of anasto-
moses in the small intestine of the rat.entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Study design
Hundred and fiftynine male Wistar rats weighing
250–290 g (Charles River, Sulzfeld, Germany) were
housed 2 per cage and accustomed to laboratory condi-
tions for five days before the start of the experiment. All
rats underwent intestinal resection and an anastomosis
was constructed in the ileum. Animals were observed
closely and weighed daily and had free access to water
and standard rodent chow (Hope Farms, Woerden, The
Netherlands) throughout the entire experimental period.
When observing the rats attention was paid to activity,
colour and aspect of nose, presence of diarrhoea, aspect
of fur and tenderness of the abdomen. If the rats scored
as abnormal on all of these points they were taken out
of the experiment, always after consultation of one of
the experienced biotechnicians.
In experiment 1, 84 rats were randomly divided into
two cohorts of 42 rats, each consisting of three groups
of 14 animals to be killed on day 1, 2 or 3 after surgery.
The controls were administered buprenorphine and the
experimental animals received carprofen as an analgetic
(Table 1). Ten rats from each group were analysed for
wound strength and the remaining animals were used
for histology.
In experiment 2, 45 rats were randomly divided over
three equal groups. All received carprofen for three days,
starting immediately after surgery or 1 or 2 days after-
wards. Animals in the three groups were killed on day 3,
4 or 5 after surgery, respectively (Table 2). Twelve rats
from each group were analysed for wound strength and
the remaining animals were used for histology.
In experiment 3, 30 rats were divided into three equal
groups which each received a different daily (full, half or
quarter, see below) dose of carprofen from the day of
surgery. All animals were killed at day 3 (Table 3) and
analysed for wound strength.
The Animal Ethics Review Committee of the Radboud
University Nijmegen approved the study (RU-DEC
2011–015 and 2011–127).
Surgery and analgesics
Procedures were performed under semi sterile condi-
tions using a Zeiss operation microscope (Carl Zeiss AG,Table 1 Characteristics of experiment 1
Buprenorphine
Day of termination 1 2 3
Number operated at day 0 14 14 14
Premature death (day) 0 1 (0) 0
Anastomotic leakage 0 0 0
After termination 10 animals from each group were analysed for wound strength a
paid to signs of anastomotic leakage. P-values denote significant differences betwe
two-sided test).Oberkochen, Germany). Animals were anesthetized by
use of a mixture of isoflurane, oxygen and nitrogen,
while breathing spontaneously through a mask.
A midline laparotomy was performed and in each rat a
0.5-cm segment was resected from the distal ileum,
15 cm proximal to the coecum. Ileal continuity was
restored by constructing an end-to-end anastomosis
with 8 single-layer, inverting, interrupted sutures
(Ethilon 8–0; Ethicon, Norderstedt, Germany).
The abdominal wall was closed with a running suture
(Vicryl 3–0; Ethicon, Norderstedt, Germany). The skin
was closed with staples. During operations, body tem-
perature was kept at 38°C using a heating pad and a
lamp. Intestines were covered with gauze pads soaked
with 0.9% NaCl to minimize desiccation. To prevent de-
hydration, 10 ml of 0.9% NaCl was administered sub-
cutaneously after the operation.
All rats in experiment 2 and 3 and the rats in the con-
trol group of experiment 1 were administered bup-
renorphine (Temgesic, Schering Plough, Houten, the
Netherlands), 0.02 mg/kg subcutaneously every 12 h for
48 h the first dose was administered just prior to sur-
gery. This constitutes the analgesic regimen routinely
given in our intestinal anastomosis model. In experiment
1, rats in the experimental group received only carprofen
(Rimadyl, Pfizer Animal Health, Capelle aan de IJssel,
the Netherlands), 5 mg/kg subcutaneously daily immedi-
ately before surgery and on days 1 and 2. In experiment
2 animals received 3 daily doses of carprofen (5 mg/kg)
starting on the day of surgery or 1 or 2 days afterwards.
The rats in experiment 3 received carprofen in different
doses (5, 2.5 and 1.25 mg/kg, respectively) on the day of
surgery and the next 2 days.
Necropsy and analysis of wound strength
The rats were killed by CO/CO2 asphyxiation. The abdo-
men was inspected and particular attention was paid to
signs of anastomotic leakage defined such as macroscopic
dehiscence of the anastomosis, the presence of faecal peri-
tonitis or a puncture in the anastomotic line with or with-
out an abscess near it. If necessary (in order to resect the
segment) adhesions were dissected carefully without ma-
nipulation of the anastomosis proper. Segments contain-
ing the anastomoses were resected en bloc.Carprofen
1 2 3
14 14 14
0 0 1 (2)
6(p = 0.02) 8(p = 0.002) 11(p = <0.0001)
nd the remaining animals for histology. At obduction, special attention was
en each carprofen group and the corresponding buprenorphine group (Fisher’s
Table 2 Characteristics of experiment 2
Administration
of carprofen
from day 0
Administration
of carprofen
from day 1
Administration
of carprofen
from day 2
Day of
termination
3 4 5
Number
operated at
day 0
15 15 15
Premature
death (day)
0 2 (3,3) 0
Anastomotic
leakage
12 7 3(p = 0.0028)
After termination 12 animals in each group were analysed for wound strength
and the remaining animals for histology. Signs of anastomotic leakage were
noted at obduction. P-value denotes a significant difference with the group
administered carprofen from day 0 (Fisher’s two-sided test).
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infused (2 ml/min) with 0.9% NaCl containing methy-
lene blue. The maximum pressure (mmHg) recorded im-
mediately before sudden loss of pressure was taken as
the bursting pressure. The site of rupture (within or out-
side the anastomotic line) was noted. Subsequently, the
same segments were placed in a tensiometer, and the
breaking strength (g) was measured [7]. The anastomotic
segments were carefully cleaned from any adhering tis-
sue and 5 mm samples, containing the suture line in the
middle, were frozen in liquid nitrogen and stored at
−80°C until further processing.
Biochemical analysis
After weighing, tissue samples were frozen, lyophilized
and pulverized. The hydroxyproline content, as a meas-
ure of the collagen content, was measured in experiment
1 by high-performance liquid chromatography (HPLC)
after hydrolysis with 6 N hydrochloric acid and coupling
to dabsyl-chloride.
In experiment 1gelatin zymography was performed.
Tissue extracts were prepared using a buffer containing
1% (v/v) Triton X-100. The protein concentration of the
extracts was measured using the bicinchoninic acidTable 3 Characteristics of experiment 3
Full dose
carprofen
Half dose
carprofen
Quarter dose
carprofen
Number operated
at day 0
10 10 10
Day of
termination
3 3 3
Premature death
(day)
1 (2) 0 1 (3)
Anastomotic
leakage
9 8 6
All animals, except those who died prematurely, were terminated at day 3 and
analysed for wound strength. Signs of anastomotic leakage at obduction were
noted.reagent. All tissue samples were stored at −80°C until
zymography. The techniques for preparation and elec-
trophoresis of the gels and quantification of the various
enzyme activities have been described previously [8].
Histology
Intestinal samples of approximately 1 cm containing
the entire anastomosis in the middle were carefully
collected en bloc, opened at the mesenteric side,
washed gently in 0.9% NaCl and spread out in a cas-
sette for paraffin-embedding. From paraffin-embedded
tissues, 4 μm sections were prepared and stained with
hematoxylin and eosin (H&E). The presence of COX-
1 and COX-2 protein in healing anastomoses was
visualized by immunohistochemistry. From the
paraffin-embedded tissues 4 μm sections were pre-
pared and stained as described previously [6]. COX-1
and COX-2 proteins were visualized using a rabbit
polyclonal antiserum against human COX-1 and
COX-2 (Cayman Chemical, An Arbor, MI, USA).
Statistics
Comparison between more than two groups was per-
formed using a One-way Analysis of Variance (ANOVA).
Comparisons between two groups or, within one group,
between values at two different days were performed
with a two-tailed unpaired t-test. Results were consid-
ered statistically significant at p < 0.05.
Results
Presence of COX during normal healing
Both COX-1 and COX-2 are expressed during normal
healing, if buprenorphine is used for peroperative pain
relief. Figure 1 shows COX-1 to be present in undam-
aged intestine and also at day 1, 2 and 3 after surgery
(Figure 1 panels a-d). COX-2 is absent in undamaged in-
testine but appears at day 1 and, more strongly, at days
2 and 3 (Figure 1 panels e to h).
Experiment 1: carprofen versus buprenorphine
All animals lost weight after operation. In the buprenor-
phine group the mean (+ SEM) relative weight (vs weight
at operation) was 91 ± 1% at day 3. The corresponding
value in the carprofen group was 94 ± 2% (p = 0.0356).
One rat from the buprenorphine group died immediately
after surgery of no discernible reason. In the carprofen
group another rat died prematurely from anastomotic
leakage. No signs of anastomotic leakage were observed in
the buprenorphine groups. These signs were found in-
creasingly with time, and significantly (p < 0.05) more fre-
quently at all days, in the carprofen groups (Table 1).
The anastomotic bursting pressure is depicted in
Figure 2A. The biggest difference between groups was
observed at day 3 where values in the buprenorphine
Figure 1 Presence of COX-1 and COX-2 during normal healing.
Anastomotic segments from the buprenorphine group of
experiment 1 were immunostained for COX-1 (panels on the left)
and COX-2 (panels on the right). Panels represent uninjured intestine
(a and e) and tissue segment with the anastomosis in the middle
and the mucosal layer on top (at a magnification of approximately
x100) at day 1 (b and f), 2 (c and g) and 3 (d and h) after surgery.
Figure 2 Anastomotic strength in experiment 1. Animals
received either buprenorphine or carprofen from the day of
operation and were terminated at day 1, 2 or 3 after operation.
Panel A gives the individual bursting pressures (and means as
horizontal bars) for all animals: black circle denotes an absence of
signs of anastomotic leakage and ○ the presence of such signs. The
bursting site was always in the anastomotic line. In panel B bars
represent mean (+ SEM) for breaking strength.
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group 34 ± 10 mm Hg (p = 0.0915). Clearly, in the carpro-
fen groups the bursting pressure was lowest in animals
who displayed signs of anastomotic leakage. At day 3, the
average anastomotic breaking strength (Figure 2B) was
also lower (p = 0.0729) in the carprofen group than in the
buprenorphine group, at 26 ± 7 vs 44 ± 6 g, respectively.
Gelatin zymography revealed the presence of both
pro- and active MMP-2 and −9 in anastomotic extracts.
At days 1 and 2 no differences were found for any of
these activities between buprenorphine and carprofen
groups (data not shown). At day 3, total activities (in ar-
bitrary units/sample) for both pro-MMP-2 and active
MMP-2 were higher in the buprenorphine groups:
571 ± 62 vs 313 ± 35 (p = 0.0038) and 223 ± 21 vs 133 ± 9
(p = 0.0024) respectively. The anastomotic hydroxypro-
line content did not significantly differ between groups
at any of the days (Figure 3).Experiment 2: delayed administration of carprofen
Weight loss was similar to that observed in experiment
1, with the relative weight at day 3 averaging 93, 91 and
93% in the groups receiving carprofen from day 0, 1 or
2, respectively. Two rats which received carprofen from
day 1 after surgery died prematurely on day 3 due to
anastomic leakage. As before, signs of anastomotic leak-
age were seen frequently if carprofen was given from day
0 (Table 2). Delaying the first gift reduced leakage, sig-
nificantly so if carprofen was only given from day 2 on-
wards, although in that group signs were still observed
in 20% of the animals after termination at day 5. Anasto-
motic strength did increased with time. Despite the fact
that the animals also received a three day course of car-
profen both anastomotic bursting pressure and breaking
strength at day 5 were considerably and significantly
(p < 0.001) higher than at day 3 (Figure 4). Again, the
bursting pressure was lowest in animals who displayed
signs of anastomotic leakage.
Experiment 3: different dosage of carprofen
The weight loss was similar to that in the preceding
experiments, with a mean relative weight (vs weight at
Figure 3 Anastomotic hydroxyproline content in experiment 1.
Bars represent mean and SEM (in μg hydroxyproline/5 mm tissue) in
anastomotic segments from both the buprenorphine and the
carprofen groups at the various days after operation.
Figure 4 Anastomotic strength in experiment 2. Animals
received carprofen beginning at the day of operation or the first or
second day thereafter and were terminated 3 days later. Panel A
gives the individual bursting pressures (and means as horizontal
bars) for all animals: black circle denotes an absence of signs of
anastomotic leakage and ○ the presence of such signs, while black
triangle indicates that the bursting site was outside the anastomotic
line. In panel B bars represent mean (+ SEM) for breaking strength.
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ceiving full, half or quarter doses of carprofen, respect-
ively. One rat died prematurely of anastomotic
dehiscence in the group which received the full dose of
carprofen and another one, of unknown reasons, in the
group that received a quarter dose.
Signs of anastomotic leakage were abundant in all
groups (Table 3). Although the incidence decreased with
dose, this effect remained non-significant with the
current cohort size.
The average bursting pressure rose slightly with de-
creasing dosage of carprofen but did not differ signifi-
cantly between groups (Figure 5). Animals without signs
of anastomotic leakage showed the highest anastomotic
bursting pressure. Breaking strength was similar in all
groups.
Discussion and conclusion
Carprofen interferes with early repair of ileal anasto-
moses in the rat. Signs of anastomotic leakage comprise
the main outcome parameter in this study. If carprofen
is used from the day of operation, these signs are already
abundantly present 24 hours later. Delaying the first gift
of carprofen for 48 hours significantly reduces signs of
leakage, without completely preventing them. Reducing
the dose fourfold lowers the incidence of this complica-
tion, but not significantly so.
NSAIDs are commonly used in small animals and
equine practice for peri-operative pain relief because of
their analgetic and anti-inflammatory features. NSAIDs
inhibit the family of COX enzymes. COX-2 is expressed
mainly in response to external stimuli and is postulated to
be involved in essentially pathological conditions such as
inflammation, pain and fever [9]. Selective inhibitors of
COX-2 supposedly allow specific targeting of inflamma-
tory disease processes, without disruption of normal
homeostatic mechanisms that accounts for many side-
effects of non-selective NSAID therapy. Both COX-1 and−2 are believed to be involved in wound healing [10,11]
and Figure 1 demonstrates their presence in the healing
anastomosis. There is a growing understanding that
NSAIDs, and especially those with a certain preference for
COX-2, may increase the risk of anastomotic leakage
[12,13]. Carprofen is such a drug that is used in domestic
animals [14], but is also effective as an analgesic in labora-
tory animals undergoing laparotomy [15]. Recent evidence
shows that its long-term use can inhibit bone healing in
dogs [16], but nothing is known about its potential effects
on soft tissue healing. Recent incidental reports suggest
that carprofen administration to dogs alters functions of
platelets, which are relevant to the repair sequence [17].
Also, carprofen has been shown to compromise the integ-
rity and barrier function of the gastrointestinal mucosa in
dogs [18]. The present data, which expand on a previous
short communication [5] unequivocally demonstrate that
carprofen can interfere significantly with anastomotic in-
tegrity in the rat small bowel.
Figure 5 Anastomotic strength in experiment 3. Animals
received different doses of carprofen from the day of operation and
were terminated at day 3 after operation. Panel A gives the
individual bursting pressures (and means as horizontal bars) for all
animals: black circle denotes an absence of signs of anastomotic
leakage and ○ the presence of such signs. The bursting site was
always in the anastomotic line. In panel B bars represent mean
(+ SEM) for breaking strength.
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surpass those in the buprenorphine group (Table 1), the
average anastomotic strength is not dramatically reduced
(Figure 1). It seems likely that in the majority of animals
the leakage can be contained, e.g. by the formation of fi-
brinous adhesions. This way, some degree of strength is
restored to the anastomotic segment. On the whole
though, throughout the three experiments anastomoses
which display signs of leakage at necropsy display lower
bursting pressures than those that are free of such signs.
These findings raise the question what the fate would
have been of the animals which survive until day 3 or
later, but which show signs of leakage. Most likely, those
with zero bursting pressure, thus in fact with a gap in
the suture line at that time, will eventually die from sec-
ondary peritonitis. However, the possibility cannot be
excluded that in some cases a fibrinous adhesion barrier
will prevent full feacal leakage into the abdominal cavity.
The resulting subclinical leakage could eventually allow
complete healing of the intestinal wall. just as the major-
ity of animals with anastomotic strength compatible with
normal repair at day 3 may be expected to survive andshow increasing strength in the proliferative phase of
healing (as observed in the animals in experiment 2).
From the data presented it is clear that, whatever
mechanism is responsible for leakage to occur, the origin
of the phenomenon must lie within the first days after
operation. It is not confined to the first 24, or even 48,
hours since in the group where carprofen was first given
at day 2, 20% of the animals still showed proof of leakage
3 days later (Table 2). Thus, carprofen somehow affects
the inflammatory phase of healing, where anastomotic
integrity is determined by the capacity of the existing
submucosal matrix to retain sutures. Induction of
massive matrix degradation seems unlikely since hydro-
xyproline (collagen) levels in the anastomotic segments
remain unaffected. Also, total activities of MMP-2 and
MMP-9 remain unchanged during the first 2 days. These
results do not exclude the possibility of limited and local
matrix degradation, e.g. around the sutures, by one of
the other enzymes from the MMP family. Still, it is
believed that COX-2 inhibitors generally suppress MMP
activity [19].
It has been suggested that COX-2 plays a regulatory
role in maintaining gastrointestinal barrier function and
motility and is needed to maintain small bowel integrity
[20,21].
Interestingly, the effect described here does not occur in
colonic anastomoses [5] while the highest level of COX-2
expression in normal uninjured rats is located on the ileal
side of the ileocaecal junction [22]. The question then
arises if the carprofen effect is mediated specifically
through COX-2 and if it is species specific. It has been
suggested that determining the exact specificity of any in-
hibitor for either of the COX enzymes is frought with
practical difficulties and may depend on the test and the
laboratory that uses it [4]. Still, carprofen seems to possess
a certain degree of specificity for COX-2, although it may
vary between species. Thus, as yet the question remains if
these findings are limited to laboratory animals or that
they can also occur in dogs and cats. Using a commer-
cially available formulation and the manufacturer’s recom-
mended dose it seems likely that carprofen also produces
significant inhibition of COX-1 [4]. Very recent data from
our own laboratory suggest that diclofenac, another in-
hibitor with specificity for COX-2, shows effects similar
to carprofen, while naproxen, with a suspected lesser
specificity for COX-2, leaves ileal anastomoses intact (un-
published results), Older data indicate increased complica-
tions in rats with anastomoses in both ileum and colon
after preoperative administration of either ibuprofen or
indomethacin [23]. It thus remains to be determined if
preference for COX-2 is essential for a drug to exert the
negative effects observed.
It is necessary to gain knowledge about the potential
drawbacks of NSAID’s like carprofen, as they are rapidly
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are able to minimize post-operative opioid requirement
in veterinary practice and in experimental studies [2-24].
The findings reported here may also be relevant to the
human situation where NSAIDs are frequently used after
gastro-intestinal surgery and are even incorporated in
protocols for fast track surgery, despite emerging evi-
dence that they may affect repair [12,13].
Thus, we conclude that carprofen interferes with
wound healing in the rat ileum at a very early stage. If it
does not kill the animal, at least it renders it more vul-
nerable to second hits after initial surgery. Although the
mechanisms responsible remain to be fully understood,
there appears to be an increasing body of evidence
which suggests that one should be aware that NSAIDs
may affect the outcome of the wound healing sequence.
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